Xuebijing Injection
2017ZDSYLL025-P01
Approved small_molecule completed
Quick answer
Xuebijing Injection for Sepsis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Sepsis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed